Fol. Biol. 2016, 62, 110-119
https://doi.org/10.14712/fb2016062030110
Importance of Tumour Suppressor Gene Methylation in Sinonasal Carcinomas
References
1. Barnes, L., Eveson, J. W., Reichart, P., Sidransky, S. (eds) (2005) World Health Organization Classification of Tumours. Pathology and Genetics. Head and Neck Tumours. pp. 9-80, IARC Press, Lyon.
2. 2008) DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment. Gynecol. Oncol. 109, 129-139.
< , C. A., Hacker, N. F., Clark, S. J., O’Brien, P. M. (https://doi.org/10.1016/j.ygyno.2007.12.017>
3. 2013) Promoter methylation of GATA4, WIF1, NTRK1 and other selected tumour suppressor genes in ovarian cancer. Folia Biol. (Praha) 59, 87-92.
, M., Dvořáková, E., Špaček, J., Laco, J., Mžik, M., Palička, V. (
4. 2014) Methylation patterns of estrogen receptor α promoter correlate with estrogen receptor α expression and clinicopathological factors in hepatocellular carcinoma. Exp. Biol. Med. (Maywood, N. J.). 239, 883-890.
< , B., Geng, L., Yu, Y., Sui, C., Xie, F., Shen, W., Zheng, T., Yang, J. (https://doi.org/10.1177/1535370214536651>
5. 2004) DNA methylation and cancer. J. Clin. Oncol. 22, 4632-4642.
< , P. M., Singal, R. (https://doi.org/10.1200/JCO.2004.07.151>
6. 2011) Role of DNA methylation in head and neck cancer. Clin. Epigenetics 2, 123-150.
< , S., Dalay, N. (https://doi.org/10.1007/s13148-011-0045-3>
7. 2003) Epigenetic inactivation of RASSF1A in head and neck cancer. Clin. Cancer Res. 9, 3635-3640.
, S. M., Sun, D. I., Benoit, N. E., Kuzmin, I., Lerman, M. I., Sidransky, D. (
8. 2007) The RASSF1A tumor suppressor. J. Cell Sci. 120, 3163-3172.
< , H., Vos, M. D., Clark, G. J. (https://doi.org/10.1242/jcs.010389>
9. 2009) DNA hypermethylation of ESR1 and PGR in breast cancer: pathologic and epidemiologic associations. Cancer Epidemiol. Biomarkers Prev. 18, 3036-3043.
< , M. M., Campan, M., Figueroa, J. D., Yang, X. R., Lissowska, J., Peplonska, B., Brinton, L. A., Rimm, D. L., Laird, P. W., Garcia-Closas, M., Sherman, M. E. (https://doi.org/10.1158/1055-9965.EPI-09-0678>
10. 2013) Sinonasal carcinomas: epidemiology, pathology, and management. Neurosurg. Clin. N. Am. 24, 39-49.
< , S. K., Gullane, P. J., Witterick, I. J., Zweifel, C., Gentili, F. (https://doi.org/10.1016/j.nec.2012.08.004>
11. 2007) The role of RASSF1A methylation in cancer. Dis. Markers 23, 73-87.
< , L. B., Cooper, W. N., Latif, F. (https://doi.org/10.1155/2007/291538>
12. 2008) Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factors. Int. J. Cancer 123, 2331-2336.
< , Z., Cheng, Y., Olaru, A., Kan, T., Yang, J., Paun, B., Ito, T., Hamilton, J. P., David, S., Agarwal, R., Selaru, F. M., Sato, F., Abraham, J. M., Beer, D. G., Mori, Y., Shimada, Y. Meltzer, S. J. (https://doi.org/10.1002/ijc.23804>
13. 2014) Differences in methylation profiles between HPV-positive and HPV-negative oropharynx squamous cell carcinoma: a systematic review. Epigenetics 9, 194-203.
< , P. M., Noorlag, R., Braunius, W. W., Stegeman, I., Willems, S. M., Grolman, W. (https://doi.org/10.4161/epi.26881>
14. 2014) Screening of differential promoter hypermethylated genes in primary oral squamous cell carcinoma. Asian Pac. J. Cancer Prev. 15, 8957-8961.
< , G. H., Froemming, G. R., Zain, R. B., Abraham, M. T., Thong, K. L. (https://doi.org/10.7314/APJCP.2014.15.20.8957>
15. 2015) The presence of high-risk human papillomavirus (HPV) E6/E7 mRNA transcripts in a subset of sinonasal carcinomas is evidence of involvement of HPV in its etiopathogenesis. Virchows Arch. 467, 405-415.
< , J., Sieglová, K., Vošmiková, H., Dundr, P., Němejcová, K., Michálek, J., Čelakovský, P., Chrobok, V. Mottl, R., Mottlová, A., Tuček, L., Slezák, R., Chmelařová, M, Sirák, I, Vošmik, M., Ryška, A. (https://doi.org/10.1007/s00428-015-1812-x>
16. 2000) The p53/p63/p73 family of transcription factors: overlapping and distinct functions. J. Cell Sci. 113, 1661-1670.
< , M., De Laurenzi, V., Costanzo, A., Gong, J., Wang, J. Y., Melino, G. (https://doi.org/10.1242/jcs.113.10.1661>
17. 2013) Molecular characterisation of sinonasal carcinomas and their clinical implications. Acta Otorrinolaringol. Esp. 64, 289-296.
< , F., Llorente, J. L., Costales, M., García-Inclán, C., Pérez-Escuredo, J., Alvarez-Marcos, C., Hermsen, M., Suárez, C. (https://doi.org/10.1016/j.otorri.2012.03.002>
18. 2014) Promoter hypermethylation using 24-gene array in early head and neck cancer: better outcome in oral than in oropharyngeal cancer. Epigenetics 9, 1220-1227.
< , R., van Kempen, P. M., Moelans, C. B., de Jong, R., Blok, L. E., Koole, R., Grolman, W., van Diest, P. J., van Es, R. J., Willems, S. M. (https://doi.org/10.4161/epi.29785>
19. 2005) Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res. 33, e128.
< , A. O., Ameziane, N., Duarte, H. M., Vijzelaar, R. N., Waisfisz, Q., Hess, C. J., Schouten, J. P., Errami, A. (https://doi.org/10.1093/nar/gni127>
20. 2011) Altered methylation at microRNA-associated CpG islands in hereditaryand sporadic carcinomas: a methylation-specific multiplex ligation-dependent probe amplification (MSMLPA)- based approach. Mol. Med. 17, 726-735.
< , W., Perkiö, E., Kaur, S., Peltomäki, P. (https://doi.org/10.2119/molmed.2010.00239>
21. 2013) ESR1 gene amplification in endometrial carcinomas: a clinicopathological analysis. Anticancer Res. 33, 3775-3781.
, M. T., Nakayama, K., Rahman, M., Ishikawa, M., Katagiri, H., Katagiri, A., Ishibashi, T., Sato, E., Iida, K., Ishikawa, N., Nakayama, N., Miyazaki, K. (
22. 2014) Estrogen receptor mutations in breast cancer – new focus on an old target. Clin. Cancer Res. 20, 1724-1726.
< , C. V., Dowsett, M. (https://doi.org/10.1158/1078-0432.CCR-14-0067>
23. 2007) Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker. Oral Oncol. 43, 82-87.
< , D., Zhang, Z., Van do, N., Huang, G., Ernberg, I., Hu, L. (https://doi.org/10.1016/j.oraloncology.2006.01.007>
24. 2013) Detection of human papillomavirus in sinonasal carcinoma: systematic review and meta-analysis. Hum. Pathol. 44, 983-991.
< , K., Syrjänen, S. (https://doi.org/10.1016/j.humpath.2012.08.017>
25. 2002) Incidence and survival in patients with sinonasal cancer: a historical analysis of population- based data. Head Neck 34, 877-885.
< , J. H., Reh, D. D. (https://doi.org/10.1002/hed.21830>
26. 2014) Epigenetic changes of TIMP-3, GSTP-1 and 14-3-3 σ genes as indication of status of chronic inflammation and cancer. Int. J. Biol. Markers 29, e208-214.
< , Y. J., He, L., Yuan, M., Tsang, W. W., Hao, L., Wang, M., Chow, L. W., Cheung, M. N., Liu, Q., Ng, E. L., Loo, W. T., Chow, C. Y., Bai, L. J., Yang, Z. (https://doi.org/10.5301/jbm.5000104>
27. 2003) Differential gene methylation in undifferentiated nasopharyngeal carcinoma. Int. J. Oncol. 22, 869-874.
, T. S., Tang, K. C., Kwong, D. L., Sham, J. S., Wei, W. I., Kwong, Y. L., Yuen, A. P. (
28. 2015) Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation- sensitive high resolution melting. Int. J. Cancer 136, E127-135.
, X., Dai, W., Kwong, D. L., Szeto, C. Y., Wong, E. H., Ng, W. T., Lee, A. W., Ngan, R. K., Yau, C. C., Tung, S. Y., Lung, M. L. (
29. Zvolský, M. (2014) Incidence of Malignant Neoplasms in the Czech Republic in 2011. IHIS, Volume 25, Prague, Czech Republic. (in Czech)